CMRX – chimerix, inc. (US:NASDAQ)

News

Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium [Yahoo! Finance]
Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Chimerix to Speak Today at The White House Cancer Moonshot Forum
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com